• 5th Floor. Amrita Tower, KPCC Junction, MG Road Kochi

News and Media Coverage

Balacovin: Kerala firm PNB Vesper Life gets nod for phase 3 clinical trial of Covid drug

A Covid-19 drug manufactured by Kerala-based company, PNB Vesper, has received nod by DCGI to conduct Phase 3 clinical trials. The company will be conducting a nationwide multi-centred clinical trial of the drug- PNB-001 (GPP-BALACOVIN), on Covid-19 patients who are … Continued

READ MORE
PNB Vesper gets DCGI nod to conduct Ph III trials on COVID-19 drug

Kerala-based pharmaceutical organization PNB Vesper has received DCGI permission to conduct the final phase 3 clinical trials. After a detailed deliberation by the Subject Expert Committee (SEC) on the Phase 2 Clinical Trial results of PNB-001 (GPP-BALACOVIN), the company has … Continued

READ MORE
PNB Vesper gets DCGI nod to begin phase III trials for PNB 001/GPP-Balacovin for Covid-19 treatment

PNB Vesper, a leading Kerala-based life sciences company received permission from the DCGI and entering into the final phase 3 clinical trials. After a detailed deliberation by the Subject Expert Committee (SEC) on the phase 2 clinical trial results of … Continued

READ MORE
PNB Vesper to conduct Phase III clinical trials on covid drug, gets DCGI nod

The Phase 3 trial will be conducted on a large patient population in 12 hospitals all over India. GPP- BALACOVIN is a novel and safe drug that possesses significant efficacy to save the hospitalised patients with oxygen support, from the … Continued

READ MORE
DCGI allows PNB Vesper Life Science to conduct phase-III clinical trials on PNB 001/GPP-BALACOVIN to treat COVID-19

PNB Vesper has received permission from the Drugs Controller General of India (DCGI) to enter into the phase-III clinical trials of PNB 001/GPP-BALACOVIN, the company said in a statement. After a detailed deliberation by the Subject Expert Committee (SEC) on … Continued

READ MORE
PNB Vesper completes COVID-19 Phase 2 Clinical Trial

Kerala-based life sciences company PNB Vesper announced that it has successfully completed the COVID-19 Phase 2 Clinical Trials and submitted the final report of its proprietary drug PNB-001 (GPP-Baladol) to the Drug Controller General of India (DCGI). GPP-Baladol is a … Continued

READ MORE
Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drug

Kochi-based PNB Vesper Life Sciences NSE 1.17 % has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency … Continued

READ MORE
Kochi firm PNB Vesper Life completes phase 2 clinical trial of Covid drug

The city-based PNB Vesper Life Sciences has successfully completed phase 2 clinical trials of PNB-001 (GPP-Baladol), its proprietary drug to treat the coronavirus infection and said it will soon move the government for deploying the drug for emergency use. The … Continued

READ MORE
PNB Vesper provides potential option to save hospitalised COVID-19 patients globally

PNB Vesper, a leading Kerala based life sciences company, has announced that it has successfully completed the phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on COVID-19 patients. The company had received approval from the Drug Controller General … Continued

READ MORE
1 2 3